Consultation on changes to support increased prescription lengths
25 July 2025
Submission on the Agenda for the 74th meeting of the Medicines Classification Committee
8 July 2025
Consultation on possible brand changes through the 2024/25 Annual Invitation to Tender
16 June 2025
Pharmac proposal to amend access to Covid-19 antivirals and change supply and reimbursement
30 May 2025
Proposed Medicines Amendment Bill 2025
19 May 2025
Proposal to regulate Physician Associates under the Health Practitioners Competence Assurance Act 2003
13 May 2025.
Proposal to support access to budesonide with eformoterol inhalers
9 May 2025
Proposal to make it easier to access Mirena and Jaydess IUDs (contraceptives)
24 April 2025
Proposal to fund Estradot as an alternative brand of oestradiol patches
15 April 2025
Proposal to fund a new type of insulin for the management of diabetes
24 March 2025
Proposal to discontinue efavirenz tablets
4 March 2025
Proposal to fund the contraceptive pill desogestrel (Cerazette)
18 February 2025
Guild expression of interest to join Pain Management Service working group
14 February 2025
Medsafe and Pharmac proposal to change the regulatory and funding restrictions for stimulant treatments for attention deficit hyperactivity disorder (ADHD)
11 February 2025
Proposal to widen access to medicines for blood cancer, inflammatory bowel diseases, eczema and rheumatoid arthritis
10 February 2025
Pharmacy council engagement on changes under consideration for Pharmacist Prescribers scope of practice
24 January 2025
Agenda for the 73rd meeting of the Medicines Classification Committee (MCC)
16 January 2025
Feedback on the Ministry of Health's proposal to extend designated prescribing authority to podiatrists
20 December 2024
Practitioner Supply Order (PSO) pilot proposal and request for Expressions of Interest (EOI)
12 December 2024
Submission on the HNZ future service model proposal for the Needle Exchange programme
10 December 2024
Feedback on proposed Disciplinary Levy and APC increases for 2025
6 December 2024
Proposal to amend the Medicines act 1981 to enable pharmacist prescribers to prescribe unapproved versions of listed medicines
31 October 2024
Proposal for the implementation of a Brand Switch Fee (BSF) due to changes in the appearance of Teva omeprazole capsules
31 October 2024
Guild submission on proposal to increase prescribing duration
21 October 2024
Proposal to remove the renewal criteria for stimulant treatments
3 October 2024
Proposal to fund lisdexamfetamine for the treatment of deficit hyperactivity disorder (ADHD)
26 September 2024
Proposal to widen access to empagliflozin for use in the treatment of chronic heart failure (HFrEF)
13 September 2024
Submission to the 2024 review of the School of Pharmacy, University of Otago
11 September 2024
Proposal to fund oestradiol gel and to award Principal Supply Status to Estrogel
15 August 2024
Objections to the decisions from the 72nd Medicines Classification Committee held on 12 June 2024
26 July 2024
Proposal to fund fosfmycin in the community for urinary tract infections and zonisamide for some types of epilepsy
26 July 2024
Proposal to widen access to immunotherapy for six types of cancer, and treatments to prevent fungal infections
26 July 2024
Proposal to fund supplements for phenylketonuria and other inherited metabolic diseases
5 July 2024
Proposal for Pharmac funding for additional Oestradiol patch prescriptions and prescription co-payments via community pharmacy
21 June 2024
Updated proposal to implement a Pharmac funding change to spacer devices
21 June 2024
Proposal re: listing and funding a ready-made Codeine Linctus product
20 June 2024
Guild request to implement an Out-of-Stock Consultation fee
11 June 2024
Targeted consultation on the strategic approach to immunisation in New Zealand
31 May 2024
Agenda of the 72nd meeting of the Medicine Classification Committee
1 May 2024
Proposal to fund levetiracetam injection for people receiving palliative care in the community
1 May 2024
Proposal to fund continuous glucose monitors, insulin pumps, and insulin pump consumables
26 April 2024
Proposal to fund treatments for gynaecological, respiratory disorders, infectious diseases and vasculitis
29 February 2024
Update on proposal from Pharmac and Te Whatu Ora to enable many childhood vaccinations to be given in pharmacies – further feedback required
15 February 2024
Proposal to decline inactive funding applications
9 February 2024
Proposal to enable to childhood vaccinations through community pharmacy
29 January 2024
Pharmacy Council consultation on Naming Policy proposed changes
25 January 2024
Proposed Disciplinary Levy and APC Fee increases for 2024/25
11 December 2023
Proposal to fund aripiprazole depot injection as an alternative antipsychotic treatment option
7 December 2023
Proposal to fund testosterone gel and award principal supply status to Testogel
22 November 2023
Agenda for the 71st meeting of the Medicines Classification Committee
19 October 2023
Proposal to amend Pharmaceutical Schedule rules to align funding with the Misuse of Drugs Amendment regulations
10 October 2023
Consultation on supporting a potential brand change for dabigatran capsules
5 September 2023
Prescribing principles for quality and safe prescribing practice
31 August 2023
Pharmac consultation on the proposed 2023-24 invitation to tender
28 August 2023
Proposed changes to the access criteria for nirmatrelvir with ritonavir, molnupiravir and remedesivir
21 August 2023
Proposal to widen access for haemophilia A and multiple sclerosis
7 July 2023
Proposal for new supply agreements for funded vaccines in the National Immunisation Schedule
26 June 2023
Proposal to fund bedaquiline and linezolid for multi-drug resistant tuberculosis (MDR-TB)
7 June 2023
Submission to include pharmacists and pharmacy technicians in the 2024 voluntary bonding scheme
1 June 2023
Proposal to fund candesartan with hydrochlorothiazide tablets for high blood pressure
1 June 2023
Proposal to phase out funding of food thickeners in the community
31 May 2023
Proposal to change the way Pulmonary Arterial Hypertension treatments are funded
17 May 2023
Barriers preventing community pharmacy from offering Boostrix
12 May 2023
Review of pholcodine-containing medicines
8 May 2023
Covid-19 antivirals - the role of molnupiravir in New Zealand's funded treatments portfolio
2 May 2023
Agenda for the 70th meeting of the Medicines Classification Committee
26 April 2023
Proposal to allow funding of spacers via prescription and supply of spacer devices by pharmacists
17 April 2023
Inclusion of one behaviour in the new Pharmacist Prescriber Competence Standards
16 April 2023